Pathology Outlines - CD5
2025年1月30日 · CD5 is a pan-T cell marker belonging to the scavenger receptor cysteine rich (SRCR) superfamily of receptors (Eur J Immunol 2016;46:1490) Used for diagnosis of …
Pathology Outlines - CD38
2023年5月18日 · Several other anti-CD38 antibodies, including bispecific anti-CD3 / CD38 antibodies, are in development or have recently been approved for treatment in multiple …
Pathology Outlines - Stains & CD markers
Hodgkin lymphoma: ALK1 CD3 CD15 CD20 CD30 CD45 (LCA) EBER1 / 2 / LMP PAX5 Leukemia: CD3 CD34 CD68 c-kit / CD117 E-cadherin MPO NPM1 PAX5 TdT Non-Hodgkin …
Pathology Outlines - CD43
2024年3月19日 · Pan T cell marker Diagnosis of myeloid (granulocytic) sarcoma (J Clin Pathol 2005;58:211) Classify subtypes of T cell lymphomas and low grade B cell lymphomas …
You are being redirected... - PathologyOutlines.com
Javascript is required. Please enable javascript before you are allowed to see this page.
Pathology Outlines - CD30
Immunohistochemical stains are performed. The neoplastic cells are positive for CD2, CD5, CD8 and CD30 and are negative for CD3, CD4, CD7, CD10, CD56, TCR alpha beta and TCR …
Pathology Outlines - Programmed death-1 (PD-1)
2021年8月23日 · Comment: CD20 highlights large atypical B cells within small B cell rich nodules. CD3 is positive in background small T cells with occasional CD3 positive T cell rosettes …
Pathology Outlines - CD56
2023年2月9日 · Marker of NK cells and NK lymphomas Detects residual myeloma and residual acute myeloid leukemia in bone marrow ( Am J Clin Pathol 2009;132:60 , Am J Clin Pathol …
Pathology Outlines - CD20
2021年9月20日 · Widely used B cell marker (also CD19, CD79a, PAX5) Retained on mature B cells until plasma cell differentiation Anti-CD20 therapy (e.g., rituximab) is available for …
Pathology Outlines - CD138
2024年6月13日 · Plasma cells. CD138 is a useful marker of plasma cells and can help support a diagnosis of multiple myeloma. Answers B, C and D are incorrect because CD138 is not a …